Quarterly report pursuant to Section 13 or 15(d)

Schedule of Capitalized Technology (Details)

v3.23.2
Schedule of Capitalized Technology (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Research and Development [Abstract]    
Balance, beginning of period $ 64,499 $ 43,038
Additional capitalized cost 61,200 45,196
Provision for amortization (23,828) (23,735)
Balance, end of period $ 101,871 $ 64,499